Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Excede Patent Expiration

Excede is a drug owned by ZOETIS INC. It is protected by 4 US drug patents filed from 2015 to 2024. All patents have expired. Details of Excede’s patents and their expiration are given below.

Filter patents by

Country : United States (US)
Patent Category : All
Drug Patent Number Drug Patent Expiry Status
Patent Data
US6074657 20 Mar, 2017 Expired
US5721359 24 Feb, 2015 Expired

Exclusivity Information

Excede holds 1 exclusivity out of which 1 has expired. Details of Excede's exclusivity codes and their expiration dates are given below.

Drug Exclusivity Drug Exclusivity Expiration
NCI Feb 21, 2015

About Excede

Excede is a drug owned by ZOETIS INC. Excede uses Ceftiofur Crystalline Free Acid as the active ingredient.

Active Ingredient:

Excede uses Ceftiofur Crystalline Free Acid as the active ingredient. Check out other Drugs and Companies using Ceftiofur Crystalline Free Acid ingredient.